BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36504889)

  • 1. Distinct promotor methylation at tumor suppressive genes in ovarian cancer stromal progenitor cells and ovarian cancer and its clinical implication.
    Ho CM; Yen TL; Chien TY; Huang SH
    Am J Cancer Res; 2022; 12(11):5325-5341. PubMed ID: 36504889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen type VI regulates the CDK4/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis.
    Ho CM; Chang TH; Yen TL; Hong KJ; Huang SH
    Am J Cancer Res; 2021; 11(3):668-690. PubMed ID: 33791147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis.
    Ho CM; Shih DT; Hsiao CC; Huang SH; Chang SF; Cheng WF
    J Transl Med; 2015 Nov; 13():367. PubMed ID: 26597084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of tumor suppressor genes in ovarian cancer.
    Ozdemir F; Altinisik J; Karateke A; Coksuer H; Buyru N
    Exp Ther Med; 2012 Dec; 4(6):1092-1096. PubMed ID: 23226780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
    Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
    Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
    S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
    Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma.
    Ho CM; Huang CJ; Huang CY; Wu YY; Chang SF; Cheng WF
    Mol Cancer; 2012 Aug; 11():53. PubMed ID: 22871047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
    Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.
    Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L
    Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
    Anwar SL; Hasemeier B; Schipper E; Vogel A; Kreipe H; Lehmann U
    PLoS One; 2019; 14(5):e0216374. PubMed ID: 31059558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
    Rasti M; Tavasoli P; Monabati A; Entezam M
    Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.